Spinal Cord Series and Cases, 2020 · DOI: 10.1038/s41394-020-0279-4 · Published: March 28, 2020
Spinal cord injury (SCI) can disrupt the neural control of the lower urinary tract (LUT), leading to neurogenic detrusor overactivity (NDO). This condition is characterized by involuntary detrusor contractions, often at low volumes, causing high detrusor pressures, feelings of urgency, urinary incontinence, and incomplete emptying. Dorsal genital nerve stimulation (DGNS) has shown promise in suppressing involuntary detrusor contractions and increasing bladder capacity. DGNS appears to work by activating the urethral sphincter and bladder neck, alongside inhibition of parasympathetic pathways and excitation of detrusor-inhibiting sympathetic pathways. This study aimed to trial on-demand, continuous or intermittent DGNS protocols, selected as appropriate for individual people with SCI depending on residual bladder sensation, using AUM to assess the effect on bladder pressure and capacity.
DGNS can be used as an adjunctive method of improving management of NDO, potentially allowing for increased bladder capacity and reduced peak storage pressures.
DGNS can increase the time between first sensation and urinary leakage, providing users with greater control over continence.
DGNS can be applied on-demand, intermittently, or continuously, allowing for personalized treatment protocols based on individual needs and bladder sensation.